The supplements to European guidelines for cervical cancer screening published by Commission
17. 09. 2015 | cancercontrol.eu
The European Commission has published the supplements to the 2nd edition of the European guidelines for cervical cancer screening.
Image: European guidelines for quality assurance in cervical cancer screening, 2nd Edition
The cervical cancer screening guidelines promote safe, equitable, reliable and cost-effective services which maximise benefits to those attending screening whilst, at the same time, minimising adverse effects. The EU guidelines from 2008 [1] provide guiding principles and evidence-based recommendations for quality assurance that should be followed when implementing screening in the member states.
By focusing on the core topics of quality assurance in primary HPV testing, organisation of HPV-based and cytology-based screening programmes, and implementation of HPV vaccination programmes, the recently published supplements [2] lay the foundation for further development of the comprehensive European guidelines in the coming years.
The continuing clear need to improve implementation of cervical cancer screening in the EU underlines the importance of re-emphasizing the European guidelines through the publication of the present supplements to the second edition.
You can download the publication from the EU bookshop (bookshop.europa.eu).
Reference
- European guidelines for quality assurance in cervical cancer screening, 2nd Edition. Luxembourg: Publications Office of the European Union, 2008. ISBN 978-92-79-07698-5. doi: 10.2772/44215
- European guidelines for quality assurance in cervical cancer screening, 2nd Edition: Supplements. Luxembourg: Publications Office of the European Union, 2015. ISBN: 978-92-79-48538-1. doi: 10.2875/859507
Keywords: cervical cancer screening, European Guidelines for Quality Assurance in Cervical Cancer Screening
